Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Matt Phipps's Stock Ratings
William Blair Analyst
Matt Phipps is an analyst at William Blair. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/14/2025
Overall Average Return
-40.0%
Smart Score
Overall Average Return Percentile
4th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/21/2025 | CNTX | Buy Now | Context Therapeutics | $0.82 | — | Matt Phipps23% | — | Initiates | → Outperform | Get Alert |
| 04/21/2025 | XNCR | Buy Now | Xencor | $8.17 | — | Matt Phipps23% | — | Initiates | → Outperform | Get Alert |
| 03/11/2025 | GMAB | Buy Now | Genmab | $19.55 | — | Matt Phipps23% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 12/12/2024 | KROS | Buy Now | Keros Therapeutics | $13.47 | — | Matt Phipps23% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 11/05/2024 | UPB | Buy Now | Upstream Bio | $8.10 | — | Matt Phipps23% | — | Initiates | → Outperform | Get Alert |
| 09/30/2024 | TENX | Buy Now | Tenax Therapeutics | $5.57 | — | Matt Phipps23% | — | Initiates | → Outperform | Get Alert |
| 04/15/2024 | CGEM | Buy Now | Cullinan Oncology | $7.62 | — | Matt Phipps23% | — | Initiates | → Outperform | Get Alert |
| 10/27/2023 | BMY | Buy Now | Bristol-Myers Squibb | $46.77 | — | Matt Phipps23% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 06/12/2023 | KDNY | Buy Now | Chinook Therapeutics | — | — | Matt Phipps23% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 03/16/2023 | KZR | Buy Now | Kezar Life Sciences | $4.23 | — | Matt Phipps23% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 11/14/2022 | JANX | Buy Now | Janux Therapeutics | $25.40 | — | Matt Phipps23% | — | Initiates | → Outperform | Get Alert |
| 11/14/2022 | GMAB | Buy Now | Genmab | $19.55 | — | Matt Phipps23% | — | Initiates | → Market Perform | Get Alert |
| 09/28/2022 | PHAS | Buy Now | PhaseBio Pharmaceuticals | — | — | Matt Phipps23% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 06/29/2022 | ALRN | Buy Now | Aileron Therapeutics | — | — | Matt Phipps23% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 11/09/2021 | INKT | Buy Now | MiNK Therapeutics | $8.15 | — | Matt Phipps23% | — | Initiates | → Outperform | Get Alert |
| 11/05/2021 | CALA | Buy Now | Calithera Biosciences | $0.00 | — | Matt Phipps23% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 10/21/2021 | TPST | Buy Now | Tempest Therapeutics | $7.20 | — | Matt Phipps23% | — | Initiates | → Outperform | Get Alert |
| 10/21/2021 | JSPR | Buy Now | Jasper Therapeutics | $4.97 | — | Matt Phipps23% | — | Initiates | → Outperform | Get Alert |
| 06/08/2021 | BIIB | Buy Now | Biogen | $123.67 | — | Matt Phipps23% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 04/08/2021 | MRUS | Buy Now | Merus | $40.95 | — | Matt Phipps23% | — | Initiates | → Outperform | Get Alert |
| 04/08/2021 | FSTX | Buy Now | F-star Therapeutics | — | — | Matt Phipps23% | — | Initiates | → Outperform | Get Alert |
| 12/18/2019 | ADRO | Buy Now | Aduro Biotech | — | — | Matt Phipps23% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 03/21/2019 | BIIB | Buy Now | Biogen | $123.67 | — | Matt Phipps23% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 07/16/2018 | KZR | Buy Now | Kezar Life Sciences | $4.23 | — | Matt Phipps23% | — | Initiates | → Outperform | Get Alert |
| 10/05/2017 | CALA | Buy Now | Calithera Biosciences | $0.00 | — | Matt Phipps23% | — | Initiates | → Outperform | Get Alert |
